Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137

Similar articles for PubMed (Select 23465062)

1.

Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine: results of two clinical trials.

Raghavan S, Maistruk G, Shochet T, Bannikov V, Posohova S, Zhuk S, Lishchuk V, Winikoff B.

Eur J Contracept Reprod Health Care. 2013 Apr;18(2):112-9. doi: 10.3109/13625187.2013.769951. Epub 2013 Mar 6.

PMID:
23465062
2.

Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan.

Raghavan S, Tsereteli T, Kamilov A, Kurbanbekova D, Yusupov D, Kasimova F, Jymagylova D, Winikoff B.

Eur J Contracept Reprod Health Care. 2013 Apr;18(2):104-11. doi: 10.3109/13625187.2013.763225. Epub 2013 Feb 7.

PMID:
23387475
4.

Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.

Schaff EA, Eisinger SH, Stadalius LS, Franks P, Gore BZ, Poppema S.

Contraception. 1999 Jan;59(1):1-6.

PMID:
10342079
5.

Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion.

Dahiya K, Mann S, Nanda S.

Arch Gynecol Obstet. 2011 Jul;284(1):59-63. doi: 10.1007/s00404-010-1590-2. Epub 2010 Jul 22.

PMID:
20652288
6.
7.

Medical management of early fetal demise using sublingual misoprostol.

Wagaarachchi PT, Ashok PW, Smith NC, Templeton A.

BJOG. 2002 Apr;109(4):462-5.

PMID:
12013170
8.

Use of mifepristone and sublingual misoprostol for early medical abortion.

Lin M, Li YT, Chen FM, Wu SF, Tsai CW, Chen TH, Kuo TC.

Taiwan J Obstet Gynecol. 2006 Dec;45(4):321-4.

PMID:
17175490
9.

Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation.

Løkeland M, Iversen OE, Engeland A, Økland I, Bjørge L.

Acta Obstet Gynecol Scand. 2014 Jul;93(7):647-53. doi: 10.1111/aogs.12398. Epub 2014 May 23.

PMID:
24766569
10.

Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial.

von Hertzen H, Huong NT, Piaggio G, Bayalag M, Cabezas E, Fang AH, Gemzell-Danielsson K, Hinh ND, Mittal S, Ng EH, Chaturachinda K, Pinter B, Puscasiu L, Savardekar L, Shenoy S, Khomassuridge A, Tuyet HT, Velasco A, Peregoudov A; WHO Research Group on Postovulatory Methods of Fertility Regulation.

BJOG. 2010 Sep;117(10):1186-96. doi: 10.1111/j.1471-0528.2010.02636.x. Epub 2010 Jun 18.

PMID:
20560941
12.

Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortion.

Creinin MD, Potter C, Holovanisin M, Janczukiewicz L, Pymar HC, Schwartz JL, Meyn L.

Am J Obstet Gynecol. 2003 Mar;188(3):664-9.

PMID:
12634638
13.

Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.

Kopp Kallner H, Fiala C, Stephansson O, Gemzell-Danielsson K.

Hum Reprod. 2010 May;25(5):1153-7. doi: 10.1093/humrep/deq037. Epub 2010 Feb 19.

14.

Extending outpatient medical abortion services through 70 days of gestational age.

Winikoff B, Dzuba IG, Chong E, Goldberg AB, Lichtenberg ES, Ball C, Dean G, Sacks D, Crowden WA, Swica Y.

Obstet Gynecol. 2012 Nov;120(5):1070-6. doi: http://10.1097/AOG.0b013e31826c315f.

PMID:
23090524
15.

Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria.

Okonofua F, Shittu O, Shochet T, Diop A, Winikoff B.

Int J Gynaecol Obstet. 2014 Apr;125(1):49-52. doi: 10.1016/j.ijgo.2013.10.009. Epub 2014 Jan 7.

PMID:
24507887
16.

Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.

Akin A, Dabash R, Dilbaz B, Aktün H, Dursun P, Kiran S, Aksan G, Doğan B, Winikoff B.

Eur J Contracept Reprod Health Care. 2009 Jun;14(3):169-75. doi: 10.1080/13625180902916020.

PMID:
19565414
17.

Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion.

Schaff EA, Fielding SL, Westhoff C.

Contraception. 2001 Aug;64(2):81-5.

PMID:
11704083
18.

Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curaçao.

Boersma AA, Meyboom-de Jong B, Kleiverda G.

Eur J Contracept Reprod Health Care. 2011 Apr;16(2):61-6. doi: 10.3109/13625187.2011.555568. Epub 2011 Feb 9.

PMID:
21303309
19.

Concurrent use of mifepristone and misoprostol for early medical abortion.

Li YT, Chen FM, Chen TH, Li SC, Chen ML, Kuo TC.

Taiwan J Obstet Gynecol. 2006 Dec;45(4):325-8.

PMID:
17175491
20.

Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy.

Schaff EA, Fielding SL, Westhoff C.

Contraception. 2002 Oct;66(4):247-50. Erratum in: Contraception. 2002 Dec;66(6):481..

PMID:
12413620
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk